M. Okamoto

发表

growth of fresh and cloned myeloma cells in vitro Effect of farnesyl transferase inhibitor R115777 (Zarnestra TM) on the

H. Matsubara, E. Ashihara, C. Shimazaki, 2013 .

Effect of farnesyl transferase inhibitor R115777 on the growth of fresh and cloned myeloma cells in vitro.

H. Matsubara, E. Ashihara, C. Shimazaki, 2003, Blood.

Human Immunodeficiency Virus (HIV)-negative, API2-MALT1 Fusion-negative Bronchus-associated Lymphoid Tissue (BALT) Lymphoma in a Young Male

E. Ashihara, H. Inagaki, C. Shimazaki, 2004, Leukemia & lymphoma.

Gamma delta T cells kill myeloma cells by sensing mevalonate metabolites and ICAM-1 molecules on cell surface.

M. Taniwaki, S. Kimura, J. Kuroda, 2007, Biochemical and biophysical research communications.

Nitrogen-containing bisphosphonate incadronate augments the inhibitory effect of farnesyl transferase inhibitor tipifarnib on the growth of fresh and cloned myeloma cells in vitro

E. Ashihara, C. Shimazaki, T. Inaba, 2005, Leukemia & lymphoma.

Hyperbaric Oxygen in Addition to Antibiotic Therapy Is Effective for Bisphosphonate-Induced Osteonecrosis of the Jaw in a Patient with Multiple Myeloma

M. Taniwaki, S. Horiike, N. Kanamura, 2006, International journal of hematology.

Malignant lymphoma presenting as a cardiac tumor and superior vena caval syndrome successfully treated by haploidentical stem cell transplantation

C. Shimazaki, A. Okano, S. Fuchida, 2005, Leukemia & lymphoma.

CD5+ Epstein‐Barr virus‐positive intravascular large B‐cell lymphoma in the uterus co‐existing with huge myoma

C. Shimazaki, A. Okano, S. Fuchida, 2005, American journal of hematology.

Plasmacytoma of the Urinary Bladder in a Renal Transplant Recipient

K. Namura, C. Shimazaki, A. Okano, 2005, International journal of hematology.

Is splenectomy a contraindication for patients with myelodysplastic syndromes complicated by splenomegaly?

K. Namura, C. Shimazaki, A. Okano, 2006, Annals of Hematology.

Rituximab is effective for steroid-refractory sclerodermatous chronic graft-versus-host disease

N. Katoh, E. Ashihara, C. Shimazaki, 2006, Leukemia.

Successful non-T-cell-depleted HLA-haploidentical stem cell transplantation (SCT) with reduced-intensity conditioning from a second child for late graft failure after the first HLA-haploidentical SCT for MDS/overt leukemia based on feto-maternal microchimerism

C. Shimazaki, E. Maruya, A. Okano, 2005, Bone Marrow Transplantation.

Expression and role of MHC class I-related chain in myeloma cells.

M. Taniwaki, C. Shimazaki, T. Inaba, 2006, Cytotherapy.

Combination Therapy with Thalidomide, Incadronate, and Dexamethasone for Relapsed or Refractory Multiple Myeloma

E. Ashihara, C. Shimazaki, A. Okano, 2005, International Journal of Hematology.

High serum bone-specific alkaline phosphatase level after bortezomib-combined therapy in refractory multiple myeloma: possible role of bortezomib on osteoblast differentiation

K. Namura, C. Shimazaki, T. Inaba, 2005, Leukemia.

The Unbalanced Chromosomal Translocation der(15)t(1;15)(q21;p13) in Multiple Myeloma

K. Namura, C. Shimazaki, A. Okano, 2005, International journal of hematology.

Unique three-way translocation, t(3;14;18)(q27;q32;q21), in follicular lymphoma.

K. Namura, C. Shimazaki, A. Okano, 2005, Cancer genetics and cytogenetics.

Toll‐like Receptors (TLRs) are expressed by myeloid leukaemia cell lines, but fail to trigger differentiation in response to the respective TLR ligands

M. Taniwaki, H. Hirai, J. Imanishi, 2009, British journal of haematology.

CD5‐negative chronic lymphocytic leukemia with indolent clinical course and autoimmune thrombocytopenia, successfully treated with rituximab

K. Namura, C. Shimazaki, A. Okano, 2004, American journal of hematology.